Logo image of NXRT

NEXPOINT RESIDENTIAL (NXRT) Stock Fundamental Analysis

NYSE:NXRT - New York Stock Exchange, Inc. - US65341D1028 - REIT - Currency: USD

38.77  -0.33 (-0.84%)

After market: 38.77 0 (0%)

Fundamental Rating

4

Taking everything into account, NXRT scores 4 out of 10 in our fundamental rating. NXRT was compared to 20 industry peers in the Residential REITs industry. There are concerns on the financial health of NXRT while its profitability can be described as average. NXRT is valued correctly, but it does not seem to be growing. NXRT also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

NXRT had positive earnings in the past year.
In the past year NXRT had a positive cash flow from operations.
NXRT had positive earnings in 4 of the past 5 years.
In the past 5 years NXRT always reported a positive cash flow from operatings.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

The Return On Assets of NXRT (2.38%) is better than 65.00% of its industry peers.
NXRT has a better Return On Equity (10.38%) than 95.00% of its industry peers.
NXRT has a worse Return On Invested Capital (1.41%) than 70.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NXRT is in line with the industry average of 2.61%.
The last Return On Invested Capital (1.41%) for NXRT is above the 3 year average (1.17%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.38%
ROE 10.38%
ROIC 1.41%
ROA(3y)0.93%
ROA(5y)2.1%
ROE(3y)4.02%
ROE(5y)9.22%
ROIC(3y)1.17%
ROIC(5y)0.96%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 17.52%, NXRT is doing good in the industry, outperforming 65.00% of the companies in the same industry.
NXRT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 12.89%, NXRT is doing worse than 70.00% of the companies in the same industry.
NXRT's Operating Margin has improved in the last couple of years.
NXRT has a Gross Margin of 94.45%. This is amongst the best in the industry. NXRT outperforms 100.00% of its industry peers.
NXRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.89%
PM (TTM) 17.52%
GM 94.45%
OM growth 3Y28.7%
OM growth 5Y6.24%
PM growth 3Y-9.45%
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y0.53%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NXRT is destroying value.
NXRT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NXRT has more shares outstanding
Compared to 1 year ago, NXRT has an improved debt to assets ratio.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.59, we must say that NXRT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.59, NXRT is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
NXRT has a debt to FCF ratio of 37.22. This is a negative value and a sign of low solvency as NXRT would need 37.22 years to pay back of all of its debts.
NXRT has a Debt to FCF ratio of 37.22. This is comparable to the rest of the industry: NXRT outperforms 60.00% of its industry peers.
A Debt/Equity ratio of 3.25 is on the high side and indicates that NXRT has dependencies on debt financing.
NXRT's Debt to Equity ratio of 3.25 is on the low side compared to the rest of the industry. NXRT is outperformed by 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.25
Debt/FCF 37.22
Altman-Z 0.59
ROIC/WACC0.18
WACC7.64%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.96 indicates that NXRT may have some problems paying its short term obligations.
NXRT has a Current ratio of 0.96. This is in the better half of the industry: NXRT outperforms 75.00% of its industry peers.
NXRT has a Quick Ratio of 0.96. This is a bad value and indicates that NXRT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.96, NXRT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.96
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

NXRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.22%, which is quite impressive.
Measured over the past years, NXRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -77.12% on average per year.
NXRT shows a decrease in Revenue. In the last year, the revenue decreased by -4.74%.
Measured over the past years, NXRT shows a quite strong growth in Revenue. The Revenue has been growing by 13.61% on average per year.
EPS 1Y (TTM)439.22%
EPS 3Y-77.12%
EPS 5YN/A
EPS Q2Q%2.78%
Revenue 1Y (TTM)-4.74%
Revenue growth 3Y10.66%
Revenue growth 5Y13.61%
Sales Q2Q%-8.22%

3.2 Future

The Earnings Per Share is expected to decrease by -280.09% on average over the next years. This is quite bad
Based on estimates for the next years, NXRT will show a small growth in Revenue. The Revenue will grow by 1.06% on average per year.
EPS Next Y3419%
EPS Next 2Y-651.65%
EPS Next 3Y-280.09%
EPS Next 5YN/A
Revenue Next Year-6.94%
Revenue Next 2Y-3.5%
Revenue Next 3Y-0.63%
Revenue Next 5Y1.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

NXRT is valuated rather expensively with a Price/Earnings ratio of 22.41.
Compared to the rest of the industry, the Price/Earnings ratio of NXRT indicates a rather cheap valuation: NXRT is cheaper than 95.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of NXRT to the average of the S&P500 Index (29.63), we can say NXRT is valued slightly cheaper.
NXRT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 22.41
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

80.00% of the companies in the same industry are more expensive than NXRT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NXRT is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.2
EV/EBITDA 18.38
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of NXRT may justify a higher PE ratio.
A cheap valuation may be justified as NXRT's earnings are expected to decrease with -280.09% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y-651.65%
EPS Next 3Y-280.09%

7

5. Dividend

5.1 Amount

NXRT has a Yearly Dividend Yield of 5.22%, which is a nice return.
Compared to an average industry Dividend Yield of 4.25, NXRT pays a better dividend. On top of this NXRT pays more dividend than 85.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, NXRT pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.22%

5.2 History

The dividend of NXRT is nicely growing with an annual growth rate of 11.83%!
NXRT has paid a dividend for at least 10 years, which is a reliable track record.
As NXRT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)11.83%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

103.92% of the earnings are spent on dividend by NXRT. This is not a sustainable payout ratio.
NXRT's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP103.92%
EPS Next 2Y-651.65%
EPS Next 3Y-280.09%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M
NXRT Dividend Payout.NXRT Dividend Payout, showing the Payout Ratio.NXRT Dividend Payout.PayoutRetained Earnings

NEXPOINT RESIDENTIAL

NYSE:NXRT (2/21/2025, 8:04:00 PM)

After market: 38.77 0 (0%)

38.77

-0.33 (-0.84%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-25 2025-02-25/bmo
Inst Owners79.85%
Inst Owner Change-93.83%
Ins Owners12.19%
Ins Owner Change3.23%
Market Cap984.76M
Analysts77.33
Price Target46.79 (20.69%)
Short Float %1.64%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield 5.22%
Yearly Dividend1.75
Dividend Growth(5Y)11.83%
DP103.92%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)168.65%
Min EPS beat(2)-27.09%
Max EPS beat(2)364.38%
EPS beat(4)3
Avg EPS beat(4)162.12%
Min EPS beat(4)-27.09%
Max EPS beat(4)364.38%
EPS beat(8)4
Avg EPS beat(8)45.31%
EPS beat(12)6
Avg EPS beat(12)83.09%
EPS beat(16)10
Avg EPS beat(16)66.95%
Revenue beat(2)1
Avg Revenue beat(2)7.31%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)16.56%
Revenue beat(4)2
Avg Revenue beat(4)8.2%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)19.44%
Revenue beat(8)3
Avg Revenue beat(8)3.44%
Revenue beat(12)5
Avg Revenue beat(12)2.31%
Revenue beat(16)6
Avg Revenue beat(16)1.16%
PT rev (1m)-2.91%
PT rev (3m)-2.65%
EPS NQ rev (1m)-52.38%
EPS NQ rev (3m)-48.84%
EPS NY rev (1m)-21.95%
EPS NY rev (3m)-23.67%
Revenue NQ rev (1m)-1.72%
Revenue NQ rev (3m)-1.47%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 22.41
Fwd PE N/A
P/S 3.72
P/FCF 25.2
P/OCF 12.01
P/B 2.2
P/tB 2.2
EV/EBITDA 18.38
EPS(TTM)1.73
EY4.46%
EPS(NY)-1.09
Fwd EYN/A
FCF(TTM)1.54
FCFY3.97%
OCF(TTM)3.23
OCFY8.32%
SpS10.43
BVpS17.6
TBVpS17.6
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.38%
ROE 10.38%
ROCE 1.78%
ROIC 1.41%
ROICexc 1.42%
ROICexgc 1.45%
OM 12.89%
PM (TTM) 17.52%
GM 94.45%
FCFM 14.76%
ROA(3y)0.93%
ROA(5y)2.1%
ROE(3y)4.02%
ROE(5y)9.22%
ROIC(3y)1.17%
ROIC(5y)0.96%
ROICexc(3y)1.18%
ROICexc(5y)0.97%
ROICexgc(3y)1.22%
ROICexgc(5y)1%
ROCE(3y)1.48%
ROCE(5y)1.22%
ROICexcg growth 3Y37.29%
ROICexcg growth 5Y7.28%
ROICexc growth 3Y35.69%
ROICexc growth 5Y6.88%
OM growth 3Y28.7%
OM growth 5Y6.24%
PM growth 3Y-9.45%
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y0.53%
F-Score8
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 3.25
Debt/FCF 37.22
Debt/EBITDA 11.04
Cap/Depr 43.93%
Cap/Sales 16.19%
Interest Coverage 0.31
Cash Conversion 62.21%
Profit Quality 84.25%
Current Ratio 0.96
Quick Ratio 0.96
Altman-Z 0.59
F-Score8
WACC7.64%
ROIC/WACC0.18
Cap/Depr(3y)222.16%
Cap/Depr(5y)409.6%
Cap/Sales(3y)84.89%
Cap/Sales(5y)157.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.22%
EPS 3Y-77.12%
EPS 5YN/A
EPS Q2Q%2.78%
EPS Next Y3419%
EPS Next 2Y-651.65%
EPS Next 3Y-280.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.74%
Revenue growth 3Y10.66%
Revenue growth 5Y13.61%
Sales Q2Q%-8.22%
Revenue Next Year-6.94%
Revenue Next 2Y-3.5%
Revenue Next 3Y-0.63%
Revenue Next 5Y1.06%
EBIT growth 1Y-21.37%
EBIT growth 3Y42.41%
EBIT growth 5Y20.7%
EBIT Next Year181.05%
EBIT Next 3Y44.31%
EBIT Next 5YN/A
FCF growth 1Y119.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.5%
OCF growth 3Y19.06%
OCF growth 5Y18.27%